B-CELL NON-HODGKIN LYMPHOMA
Clinical trials for B-CELL NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B-CELL NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for B-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supercharged immune cells take on resistant blood cancers
Disease control Not yet recruitingThis early-phase trial tests a new treatment for people with certain blood cancers (lymphomas and leukemias) that have not responded to standard therapies. The treatment uses specially engineered natural killer (NK) cells from donated cord blood, designed to better target cancer …
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
Experimental CAR-T therapy aims to tackle tough lymphoma
Disease control Not yet recruitingThis early-phase trial is testing a new CAR-T cell therapy called GI001 in 9 adults with relapsed or refractory B-cell Non-Hodgkin Lymphoma. Participants receive a single infusion of their own engineered immune cells. The main goals are to check safety and find the right dose, wh…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC
-
Experimental immune cell cocktail targets tough lymphoma
Disease control Not yet recruitingThis early-phase trial tests a new treatment for people with B-cell non-Hodgkin lymphoma that has not responded to at least two prior therapies. Participants receive donor immune cells (NK cells) along with two antibody drugs (rituximab and tafasitamab) and a support drug (IL-2) …
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated Jun 17, 2026 12:08 UTC
-
New Dual-Targeting cell therapy takes aim at Hard-to-Treat blood cancers
Disease control Not yet recruitingThis early-phase study tests a new type of immune cell therapy (CAR T cells) that targets two proteins on cancer cells at once. It is for adults with B-cell non-Hodgkin lymphoma whose cancer has not responded to or has returned after other treatments. The main goal is to find a s…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Scientists hunt for clues to chemo resistance in blood cancer
Knowledge-focused Not yet recruitingThis study collects blood and bone marrow samples from 80 people with B-cell non-Hodgkin lymphoma to explore why some cancers resist chemotherapy. Researchers will analyze the tumor and its environment, and develop lab models to test new treatments. The goal is to uncover resista…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:56 UTC